Pharmapedia Pro
Medicines/Generics/Sodium Valproate

Sodium Valproate

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Sodium Valproate is anticonvulsant drug. It acts by potentiating GABA , an inhibitory neurotransmitter. Sodium Valproate is a drug of choice in all forms of epilepsy. Sodium Valproate is also used as the free acid i.e. valproic acid, that was found to have an antiepileptic properties when used as a solvent in the search for other antiepileptic drug and Sodium Valproate is licensed for the acute manic attacks associated with bipolar disorders. The amides and esters of valproic acid are also active antileptic agents.
Indications
Sodium Valproate is primarily indicated in conditions like All forms of epilepsy, Generalized epilepsy with absence seizures, Prophylaxis of febrile convulsion, Prophylaxis of post traumatic epilepsy, Status epilepticus, and can also be given in adjunctive therapy as an alternative drug of choice in Alcohol withdrawal, Mania, Nelsons syndrome, Tardive dyskinesia.
Contraindications
Sodium Valproate
Side Effects
The severe or irreversible adverse effects of Sodium Valproate, which give rise to further complications include Thrombocytopenia. Sodium Valproate produces potentially life-threatening effects which include Pancreatitis, Liver damage, Extrapyramidal symptoms, Hyperammonemia. which are responsible for the discontinuation of Sodium Valproate therapy. The signs and symptoms that are produced after the acute overdosage of Sodium Valproate include Death, Deepening coma. The symptomatic adverse reactions produced by Sodium Valproate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Weight gain, Tremor, Hair loss, GI disorders, Hematological disorder, Leucopenia, bone marrow depression, nocturnal enuresis, curly hair development.
Warnings
Sodium valporate should be used with caution in patients with liver disease, bleeding disorder, history of a brain disorder or any allergy. It should be used caution while driving motor vehicles or performing tasks that require alertness. Before having surgery, including dental surgery, inform the doctor about the use of drug. This may interfere with urine ketone testing and give false positive results, if very high sugar readings (e.g. Over 300) are occurring, ketones may be present in urine, contact the doctor or pharmacist. It should be used with extreme caution in children under 2 years old as serious liver problems exist. The drug is not recommended for use during pregnancy or lactation, Because it may cause some neural tube defect. Avoid use in pancreatitis, porphyria. Use with caution in HIV, lupus erythematosus risk of weight gain associated with it.
High Risk Groups
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, Geriatrics, and Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
1 to 2 g (1.5 (1.5)) 12 hourly PO — As maintenance dose. 600 mg (600 (600)) As recommended. PO — should be given in two divided doses. Take after food as starting dose. Increase gradually to maintenance dose.
Child Dosage
0 to 400 mg (200 (200)) 24 hourly Oral — initial daily dose for children weighing more than 20 kg ,should be given in two divided doses 10 to 30 mg/kg (20 (20)) As recommended. Slow IV — over 3-5 minutes, maximum upto 2.5g, 20 to 30 mg/kg (25 (25)) 24 hourly Oral — Maintenance doses , exceed upto 35mg/kg 20 to 40 mg/kg (30 (30)) 24 hourly Oral — initial daily dose for children weighing less han 20 kg ,should be given in two divided doses
Neonatal Dosage
6 to 12 mg/kg (9 (9)) 8 hourly Intravenous — 6 to 12 mg/kg (9 (9)) 8 hourly Oral —
Drug Interactions
Sodium Valproate is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAspirinCarbamazepineErythromycinEthosuximideEthosuximideFosphenytoinLamotrigineMefloquine (HCl)MeropenemMethotrexatePhenobarbitonePhenytoin (Na)PrimidoneWarfarin (Na) These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Storage
Tab, Syrup Store Below 40°C. Protect from Sunlight and Heat.

Available Brands in Pakistan

23 active brands listed alphabetically.

DAPAKAN

Active

PLATINUM PHARMACEUTICALS (PVT.) LTD.

DML: DAPAKAN

TabsSyrup

DIPODIUM

Active

AMARANT PHARMACEUTICALS (PVT)

DML: DIPODIUM

SyrupTabsSyr

EPILIM

Active

SANOFI AVENTIS (PAKISTAN) LTD.

DML: EPILIM

TabsSyrup

EPILIM CHRONO

Active

SEARLE PAKISTAN (PVT.) LTD.

DML: EPILIM CHRONO

Tabs

EPIMED

Active

MEDIATE PHARMACEUTICALS (PVT) LTD

DML: EPIMED

Tabs

EPIVAL

Active

ABBOTT LABORATORIES (PAKISTAN) LIMITED.

DML: EPIVAL

SyrupTabsInj-IVInjSyr

EPIVAL-CR

Active

ABBOTT LABORATORIES (PAKISTAN) LIMITED.

DML: EPIVAL-CR

Tabs

EVALPRO

Active

KAIZEN PHARMACEUTICALS PVT LTD.

DML: EVALPRO

TabsSyr

KONTROL

Active

WERRICK PHARMACEUTICALS

DML: KONTROL

TabsSyr

LEPTIL

Active

DON VALLEY PHARMACEUTICALS (PVT) LTD.

DML: LEPTIL

TabsSuspSyr

MALPRATE

Active

MEDISURE LABORATORIES PAKISTAN (PVT.) LTD.

DML: MALPRATE

Tabs

MALPRATE-D

Active

MEDISURE LABORATORIES PAKISTAN (PVT.) LTD.

DML: MALPRATE-D

Tabs

MANAGE-EZ

Active

WILSONS PHARMACEUTICALS

DML: MANAGE-EZ

Tabs

ORIFRAL

Active

RAAZEE THERAPUTICS (PVT) LTD.

DML: ORIFRAL

Syrup

REVALP

Active

GENETICS PHARMACEUTICALS

DML: REVALP

SyrupTabs

SOPRAT

Active

NEUTRO PHARMA (PVT) LTD.

DML: SOPRAT

Liquid

TIMIGRA

Active

NAVEGAL LABORATORIES

DML: TIMIGRA

Tabs

VALEP

Active

GEOFMAN PHARMACEUTICALS

DML: VALEP

TabsSyrup

VALPRO

Active

DON VALLEY PHARMACEUTICALS (PVT) LTD.

DML: VALPRO

SyrupTabs

VALTEC

Active

GENOME PHARMACEUTICALS (PVT) LTD

DML: VALTEC

Tabs

VAZIPRO

Active

GETZ PHARMA PAKISTAN (PVT) LTD.

DML: VAZIPRO

SyrupTabsSyr

VOLPAR

Active

BRYON PHARMACEUTICALS (PVT) LTD.

DML: VOLPAR

Tabs

WIPROATE

Active

WNS FIELD PHARMACEUTICALS

DML: WIPROATE

Tabs

5 additional records are present but flagged "Unverified / Legacy" and not listed.